Literature DB >> 22095287

Necdin enhances muscle reconstitution of dystrophic muscle by vessel-associated progenitors, by promoting cell survival and myogenic differentiation.

P Pessina1, V Conti, R Tonlorenzi, T Touvier, R Meneveri, G Cossu, S Brunelli.   

Abstract

Improving stem cell therapy is a major goal for the treatment of muscle diseases, where physiological muscle regeneration is progressively exhausted. Vessel-associated stem cells, such as mesoangioblasts (MABs), appear to be the most promising cell type for the cell therapy for muscular dystrophies and have been shown to significantly contribute to restoration of muscle structure and function in different muscular dystrophy models. Here, we report that melanoma antigen-encoding gene (MAGE) protein necdin enhances muscle differentiation and regeneration by MABs. When necdin is constitutively overexpressed, it accelerates their differentiation and fusion in vitro and it increases their efficacy in reconstituting regenerating myofibres in the α-sarcoglycan dystrophic mouse. Moreover, necdin enhances survival when MABs are exposed to cytotoxic stimuli that mimic the inflammatory dystrophic environment. Taken together, these data demonstrate that overexpression of necdin may be a crucial tool to boost therapeutic applications of MABs in dystrophic muscle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095287      PMCID: PMC3321622          DOI: 10.1038/cdd.2011.160

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  33 in total

Review 1.  Aging, stem cells and tissue regeneration: lessons from muscle.

Authors:  Irina M Conboy; Thomas A Rando
Journal:  Cell Cycle       Date:  2005-03-07       Impact factor: 4.534

2.  Disruption of the mouse necdin gene results in early post-natal lethality.

Authors:  M Gérard; L Hernandez; R Wevrick; C L Stewart
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

Review 3.  Immunotherapy for melanoma.

Authors:  Jeffrey Weber
Journal:  Curr Opin Oncol       Date:  2011-03       Impact factor: 3.645

4.  Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome.

Authors:  F Muscatelli; D N Abrous; A Massacrier; I Boccaccio; M Le Moal; P Cau; H Cremer
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

Review 5.  Prader-Willi syndrome.

Authors:  S B Cassidy
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

6.  Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells.

Authors:  Takaaki Kuwajima; Hideo Taniura; Isao Nishimura; Kazuaki Yoshikawa
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

7.  TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts.

Authors:  Enrico Tagliafico; Silvia Brunelli; Anna Bergamaschi; Luciana De Angelis; Raffaella Scardigli; Daniela Galli; Renata Battini; Paolo Bianco; Sergio Ferrari; Giulio Cossu; Stefano Ferrari
Journal:  J Cell Sci       Date:  2004-09-01       Impact factor: 5.285

8.  The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues.

Authors:  Maria G Minasi; Mara Riminucci; Luciana De Angelis; Ugo Borello; Barbara Berarducci; Anna Innocenzi; Arianna Caprioli; Dario Sirabella; Marta Baiocchi; Ruggero De Maria; Renata Boratto; Thierry Jaffredo; Vania Broccoli; Paolo Bianco; Giulio Cossu
Journal:  Development       Date:  2002-06       Impact factor: 6.868

9.  Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells.

Authors:  Silvia Brunelli; Enrico Tagliafico; Fernanda G De Angelis; Rossana Tonlorenzi; Silvia Baesso; Sergio Ferrari; Michio Niinobe; Kazuaki Yoshikawa; Robert J Schwartz; Irene Bozzoni; Stefano Ferrari; Giulio Cossu
Journal:  Circ Res       Date:  2004-05-20       Impact factor: 17.367

10.  Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts.

Authors:  Maurilio Sampaolesi; Yvan Torrente; Anna Innocenzi; Rossana Tonlorenzi; Giuseppe D'Antona; M Antonietta Pellegrino; Rita Barresi; Nereo Bresolin; M Gabriella Cusella De Angelis; Kevin P Campbell; Roberto Bottinelli; Giulio Cossu
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

View more
  7 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Necdin enhances myoblasts survival by facilitating the degradation of the mediator of apoptosis CCAR1/CARP1.

Authors:  Stephanie François; Cristina D'Orlando; Tiziana Fatone; Thierry Touvier; Patrizia Pessina; Raffaella Meneveri; Silvia Brunelli
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

3.  Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage.

Authors:  Elena Rigamonti; Thierry Touvier; Emilio Clementi; Angelo A Manfredi; Silvia Brunelli; Patrizia Rovere-Querini
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

4.  Pericytes in Muscular Dystrophies.

Authors:  Louise Anne Moyle; Francesco Saverio Tedesco; Sara Benedetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Necdin, a p53 target gene, in stem cells.

Authors:  Takashi Asai; Yan Liu; Stephen D Nimer
Journal:  Oncotarget       Date:  2013-06

6.  The alpha subunit of Go modulates cell proliferation and differentiation through interactions with Necdin.

Authors:  Hyunhee Ju; Sujin Lee; Sunghak Kang; Sung-Soo Kim; Sungho Ghil
Journal:  Cell Commun Signal       Date:  2014-07-10       Impact factor: 5.712

7.  ProNGF/p75NTR Axis Drives Fiber Type Specification by Inducing the Fast-Glycolytic Phenotype in Mouse Skeletal Muscle Cells.

Authors:  Valentina Pallottini; Mayra Colardo; Claudia Tonini; Noemi Martella; Georgios Strimpakos; Barbara Colella; Paola Tirassa; Sabrina Di Bartolomeo; Marco Segatto
Journal:  Cells       Date:  2020-10-02       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.